26B-3-134. Coverage of exome sequence testing.
(1) As used in this section, "exome sequence testing" means a genomic technique for sequencing the genome of an individual for diagnostic purposes.
(2) The Medicaid program shall reimburse for exome sequence testing: for an enrollee who: is younger than 21 years old; and who remains undiagnosed after exhausting all other appropriate diagnostic-related tests; performed by a nationally recognized provider with significant experience in exome sequence testing; that is medically necessary; and at a rate set by the Medicaid program.